Compare MRKR & BHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRKR | BHV |
|---|---|---|
| Founded | N/A | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6M | 17.1M |
| IPO Year | N/A | N/A |
| Metric | MRKR | BHV |
|---|---|---|
| Price | $1.19 | $11.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $10.25 | N/A |
| AVG Volume (30 Days) | ★ 271.0K | 3.5K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.35% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,694,988.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9.06 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.81 | $8.85 |
| 52 Week High | $5.95 | $12.08 |
| Indicator | MRKR | BHV |
|---|---|---|
| Relative Strength Index (RSI) | 63.24 | 50.89 |
| Support Level | $1.15 | $10.83 |
| Resistance Level | $1.27 | $11.30 |
| Average True Range (ATR) | 0.10 | 0.21 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 87.50 | 35.25 |
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.
Blackrock Virginia Municipal Bond Trust is a perpetual closed-end municipal bond fund. Its objective is to provide current income exempt from regular Federal income taxes and Virginia personal income taxes.